Statistics for Viking Therapeutics (id:5255 VKTX)

Valuation metrics

Market cap

5.47B

Enterprise value

4.60B

Trailing P/E (ttm)

-57.79

Forward P/E

-32.52

PEG ratio

-32.52

Price/Sales (ttm)

Price/Book (mrq)

6.00

Enterprise Value/Revenue

Enterprise Value/EBITDA

-45.71

Overview

Shares outstanding

111.44M

Float

105.46M

Shares short

13.28M

% Held by insiders

0.06%

% Held by institutions

0.76%

Average volume (10 days)

5.86M

Average volume (90 days)

Price summary

52-Week low

11.54

52-Week high

99.41

52-Week change

76.65%

Beta

0.99

50-Day moving average

64.60

200-Day moving average

61.75

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-12.68%

Return on equity

-15.50%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-99,151,000.00

Diluted EPS (ttm)

-0.94

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

930.44M

Total cash per share (mrq)

8.35

Total debt (mrq)

1.24M

Total Debt/Equity (mrq)

0.14

Current ratio (mrq)

3.65K%

Book value per share (mrq)

8.18

Cash flow

Cash flow statement

-74,249,000.00

Levered free cash flow (LFCF)

-44,290,000.00